The Food and Drug Administration on Monday granted approval to a drug developed by Biogen for people with Alzheimer’s.
Here & Now‘s Robin Young speaks with Adam Feuerstein, senior writer at STAT, the health and medicine publication.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.
